BioPontis Alliance for Rare Diseases Announces Agreement with Massachusetts General Hospital on New Treatments for Huntington’s Disease

2 February 2018

Today, BioPontis Alliance for Rare Diseases, an international nonprofit organization, and Massachusetts General Hospital (MGH), the largest hospital-based research program in the United States, ann